Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Weiss

Showing results (1141-1150 of 1,173) with videos related to

Pageof 118
Sort By:
Neuro-Oncology|June 3, 2022
Management of neurofibromatosis type 1-associated plexiform neurofibromasMichael J Fisher, Jaishri O Blakeley, Brian D Weiss, et al.
Drug and Alcohol Dependence|May 4, 2020
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agendaMallory J E Loflin, Brian D Kiluk, Marilyn A Huestis, et al.
Journal of Emergency Nursing|July 14, 2010
The future of emergency medicineSandra M Schneider, Angela F Gardner, Larry D Weiss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2025
Phase I Study of <sup>131</sup>I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy TrialThomas Cash, Araz Marachelian, Steven G DuBois, et al.
Neuro-Oncology|April 8, 2022
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)Ami V Desai, Giles W Robinson, Karen Gauvain, et al.
Brain : a Journal of Neurology|June 7, 2023
Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to GJB1 variantsChristopher J Record, Mariola Skorupinska, Matilde Laura, et al.
Frontiers in Immunology|March 17, 2023
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP studyJoanna Waldock, Carol D Weiss, Wei Wang, et al.
JAMA Psychiatry|November 30, 2022
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A ReviewBrian D Kiluk, Bethea A Kleykamp, Sandra D Comer, et al.
Science Translational Medicine|April 5, 2022
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodiesSabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
The Journal of Emergency Medicine|July 17, 2010
The future of emergency medicineSandra M Schneider, Angela F Gardner, Larry D Weiss, et al.
Pageof 118

Showing results (1141-1150 of 1,173) with videos related to

Sort By:
Pageof 118
Neuro-Oncology|June 3, 2022
Management of neurofibromatosis type 1-associated plexiform neurofibromasMichael J Fisher, Jaishri O Blakeley, Brian D Weiss, et al.
Drug and Alcohol Dependence|May 4, 2020
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agendaMallory J E Loflin, Brian D Kiluk, Marilyn A Huestis, et al.
Journal of Emergency Nursing|July 14, 2010
The future of emergency medicineSandra M Schneider, Angela F Gardner, Larry D Weiss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2025
Phase I Study of <sup>131</sup>I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy TrialThomas Cash, Araz Marachelian, Steven G DuBois, et al.
Neuro-Oncology|April 8, 2022
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)Ami V Desai, Giles W Robinson, Karen Gauvain, et al.
Brain : a Journal of Neurology|June 7, 2023
Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to GJB1 variantsChristopher J Record, Mariola Skorupinska, Matilde Laura, et al.
Frontiers in Immunology|March 17, 2023
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP studyJoanna Waldock, Carol D Weiss, Wei Wang, et al.
JAMA Psychiatry|November 30, 2022
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A ReviewBrian D Kiluk, Bethea A Kleykamp, Sandra D Comer, et al.
Science Translational Medicine|April 5, 2022
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodiesSabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
The Journal of Emergency Medicine|July 17, 2010
The future of emergency medicineSandra M Schneider, Angela F Gardner, Larry D Weiss, et al.
Pageof 118